130 related articles for article (PubMed ID: 30019937)
1. Synthesis and drug efficacy validations of racemic-substituted benzimidazoles as antiulcer/antigastric secretion agents.
Radhamanalan R; Alagumuthu M; Nagaraju N
Future Med Chem; 2018 Aug; 10(15):1805-1820. PubMed ID: 30019937
[TBL] [Abstract][Full Text] [Related]
2. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H
Rajesh R; Manikandan A; Sivakumar A; Ramasubbu C; Nagaraju N
Eur J Med Chem; 2017 Oct; 139():454-460. PubMed ID: 28818769
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
4. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiulcer activities of novel 2-[(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H- benzimidazole analogues.
Yamada S; Goto T; Shimanuki E; Narita S
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):718-20. PubMed ID: 8004722
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
Bastaki SM; Chandranath I; Garner A
J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
[TBL] [Abstract][Full Text] [Related]
7. Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activity.
Terashima K; Shimamura H; Kawase A; Tanaka Y; Uenishi K; Kimura I; Ishizuka Y; Sato M
Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):166-8. PubMed ID: 7895305
[TBL] [Abstract][Full Text] [Related]
8. [Effect of a new antiulcer drug, leminoprazole, on the gastric mucosal H+,K(+)-ATPase activity in rats].
Matsukura H; Masuda M; Uchida A; Kamishiro T
Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):91-100. PubMed ID: 7927073
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds.
Uchida M; Chihiro M; Morita S; Yamashita H; Yamasaki K; Kanbe T; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1575-86. PubMed ID: 2170036
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents.
Shafik RM; El-Din SA; Eshba NH; El-Hawash SA; Desheesh MA; Abdel-Aty AS; Ashour HM
Pharmazie; 2004 Dec; 59(12):899-905. PubMed ID: 15638075
[TBL] [Abstract][Full Text] [Related]
11. Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
[TBL] [Abstract][Full Text] [Related]
12. Studies on antiulcer drugs. IV. Synthesis and antiulcer activities of imidazo[1,2-a]pyridinylethylbenzothiazoles and -benzimidazoles.
Katsura Y; Inoue Y; Nishino S; Tomoi M; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1818-22. PubMed ID: 1356644
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
14. Gastro protective and H(+), K(+)-ATPase/H. pylori inhibitory properties of pectic polysaccharides from potato.
Badanavalu Chandrashekar K; Dharmesh SM
Int J Biol Macromol; 2016 Mar; 84():385-93. PubMed ID: 26704999
[TBL] [Abstract][Full Text] [Related]
15. Antiulcer mechanisms of Vernonia condensata Baker: A medicinal plant used in the treatment of gastritis and gastric ulcer.
Boeing T; da Silva LM; Somensi LB; Cury BJ; Michels Costa AP; Petreanu M; Niero R; de Andrade SF
J Ethnopharmacol; 2016 May; 184():196-207. PubMed ID: 26956376
[TBL] [Abstract][Full Text] [Related]
16. The gastric H,K ATPase as a drug target: past, present, and future.
Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
[TBL] [Abstract][Full Text] [Related]
17. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
Shin JM; Cho YM; Sachs G
J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
[TBL] [Abstract][Full Text] [Related]
18. Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation.
Jainu M; Devi CS
J Ethnopharmacol; 2006 Mar; 104(1-2):156-63. PubMed ID: 16202548
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
Sharma R; Bali A; Chaudhari BB
Bioorg Med Chem Lett; 2017 Jul; 27(13):3007-3013. PubMed ID: 28512025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
